Kyoto Prefectural University of Medicine · Graduate School of Medicine · 准教授

Research keywords血液内科・造血器腫瘍・MDSC・多発性骨髄腫・CAR-T療法・リンパ腫・後方視的解析

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
• Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy.
• Toward further simplification of elotuzumab therapy by subcutaneous administration.
• Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system.

• 造血器腫瘍におけるMDSCを標的としたmiRNAインヒビターカクテル療法の開発
• 多発性骨髄腫におけるMDSCによる免疫制御機構の解析および治療への応用

• Official profile